Table 1.
Medications prescribed to patients with AMI at discharge between 2005 and 2016
Variable | AMI (n = 54,402) |
STEMI (n = 29,222) |
NSTEMI (n = 25,180) |
p valuea | |||
---|---|---|---|---|---|---|---|
Total no. | No. (%) | Total no. | No. (%) | Total no. | No. (%) | ||
Aspirin | 49,541 | 48,166 (97.2) | 26,440 | 25,863 (97.8) | 23,101 | 22,303 (96.5) | < 0.001 |
P2Y12 inhibitor | 49,249 | 46,039 (93.5) | 26,353 | 25,270 (95.9) | 22,896 | 20,769 (90.7) | < 0.001 |
Clopidogrel | 46,039 | 40,986 (89.0) | 25,270 | 22,487 (89.0) | 20,769 | 18,499 (89.1) | 0.780 |
Ticagrelor | 46,039 | 3,622 (7.9) | 25,270 | 1,955 (7.7) | 20,769 | 1,667 (8.0) | 0.250 |
Prasugrel | 46,039 | 1,431 (3.1) | 25,270 | 828 (3.3) | 20,769 | 603 (2.9) | 0.022 |
Statin | 49,328 | 40,469(82.0) | 26,321 | 21,807 (82.9) | 23,007 | 18,662 (81.1) | < 0.001 |
RAS blocker | 45,685 | 39,012 (85.4) | 24,479 | 21,161 (86.4) | 22,985 | 20,603 (89.6) | < 0.001 |
ACE inhibitor | 48,951 | 26,775 (54.7) | 26,162 | 15,430 (59.0) | 22,789 | 11,345 (49.8) | < 0.001 |
ARB | 48,628 | 12,647 (26.0) | 25,911 | 5,949 (23.0) | 22,717 | 6,698 (29.5) | < 0.001 |
Beta-blocker | 49,273 | 38,535 (78.2) | 26,316 | 20,988 (79.8) | 22,957 | 17,547 (76.4) | < 0.001 |
Cilostazol | 48,613 | 10,246 (21.1) | 25,932 | 6,013 (23.2) | 22,681 | 4,233 (18.7) | < 0.001 |
Calcium channel blocker | 48,368 | 4,950 (10.2) | 25,755 | 1,694 (6·6) | 22,613 | 3,256 (14·4) | < 0.001 |
Nitrate | 31,805 | 14,036 (44.1) | 18,018 | 7,740 (43·0) | 13,787 | 6,296 (45·7) | < 0.001 |
Nicorandil | 31,658 | 6,805 (21.5) | 17,956 | 3,981 (22.2) | 13,702 | 2,824 (20.6) | 0.001 |
Spirolactone | 31,285 | 2,469 (7.9) | 17,749 | 1,427 (8.0) | 13,536 | 1,042 (7.7) | 0.266 |
Diuretics | 31,662 | 6,764 (21.4) | 17,952 | 3,640 (20.3) | 13,710 | 3,124 (22.8) | < 0.001 |
AMI, acute myocardial infarction; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; RAS, renin-angiotensin system; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker.
STEMI vs. NSTEMI.